ATS Open Pivot® Aortic Valved Graft (AVG)
3905 Annapolis Lane, Suite 105
Minneapolis, Minnesota
55447
United States
|
PHONE: +1-800-399-1381
FAX: +1-763-557-2244
|
Unites the distinct advantages of the ATS Open Pivot® Heart Valve with leading graft technology for exceptional implantability and proven performance.
Product Link
PRODUCT FEATURES
Exceptional Implantability
- No tapers, no pleats; allows for easy anastomosis anywhere on the graft
- Larger graft internal diameter minimizes stress on coronary anastomosis
- Rotatable valve allows for optimal leaflet positioning
Open Pivot Design
- No recesses or cavities in the pivot area where thrombus can form1,2
- Continuous passive washing provides for gentle treatment of red blood cells, low level of hemolysis and thromboembolic events1,3
- Unique axis of suspension provides an exceptionally efficient design resulting in leaflet movement responsive to physiological demands and improved hemodynamic performance4
- Solid pyrolytic carbon orifice and strengthening band for thin yet strong orifice and large Geometric Orifice Areas (GOAs) Single plane orifice facilitates valve seating and implant regardless of suture technique
Hemashield® Woven Double Velour Graft from Boston Scientific
- Low porosity graft material improves hemostasis5,6
- Excellent resorption rates facilitate safe, uninterrupted healing6
- Exceptional handling characteristics
Indications for Use
The ATS Open Pivot Heart Valve is indicated for cardiac valve surgery and intended for the replacement of diseased, damaged or malfunctioning heart valves. ATS Open Pivot Heart Valves must be prescribed and ordered by a licensed physician.
Contraindications
There are no known contraindications to heart valve replacement with an ATS Open Pivot Heart Valve for patients who have been determined to be a candidate for mechanical heart valve replacement.
References
1. Kelly S, et al. A three-dimensional analysis of flow in the pivot regions of an ATS bileaflet valve. Int J Artif Organs 1999; 22:754-763.
2. Emery R, et al. The Initial United States Experience With the ATS Mechanical Cardiac Valve Prosthesis. The Heart Surgery Forum 2001. 2001; 4(4):346-353.
3. Emery R, et al. Five-Year Follow Up of the ATS Mechanical Heart Valve. J Heart Valve Dis. 2004; 13(2):231-8.
4. Feng Z, et al. In Vitro Hydrodynamic Characteristics Among Three Bileaflet Valves in the Mitral Position. Artif Organs 2000; 24(5):346-53.
5. Westaby S, et al. Replacement of the thoracic aorta with collagen-impregnated woven Dacron grafts. J Thorac Cardiovasc Surg 1993; 106:427-33.
6. Hirt SW, et al. Comparative in-vivo study on the healing qualities of four different presealed vascular prostheses. J Vasc Surg 1993; 17:538-45.